You are here

stem cells

Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research

Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research

Stat

Brigham and Women's

medical journals

Flag link:

Novo to create California stem cell therapy manufacturing site

Novo to create California stem cell therapy manufacturing site

Pharmaforum

drug manufacturing

Flag link:

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy

Xconomy

CRISPR Therapeutics

Flag link:

Samumed, a $12 billion startup that wants to cure baldness and smooth out your wrinkles, just raised even more funding as it plots an IPO

Samumed, a $12 billion startup that wants to cure baldness and smooth out your wrinkles, just raised even more funding as it plots an IPO

Business Insider

wrinkle treatment

Flag link:

Cellect, denovoMATRIX start stem cell research project

Cellect, denovoMATRIX start stem cell research project

Fierce Biotech

Cellect Biotechnology

drug development

Flag link:

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

FDA Halts Plan for Vertex, CRISPR Therapeutics Sickle Cell Study

Xconomy

sickle cell disease

Vertex Pharmaceuticals

CRISPR Therapeutics

Flag link:

Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies

Novo Nordisk steps up interest in diabetes, Parkinson’s stem cell therapies

Fierce Biotech

type 1 diabetes

Flag link:

Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new collaborations

Citing significant progress on a cure for diabetes, Novo Nordisk beefs up its stem cell pipeline with new collaborations

Endpoints

type 1 diabetes

Flag link:

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis

Cellular Biomedicine Group to Release 48-week Data from Phase I Clinical Trial for Promising Stem Cell Therapy AlloJoin for Knee Osteoarthritis

CP Wire

Cellular Biomedicine

osteoarthritis of the knee

Flag link:

Amgen bets on stem cell company Fortuna Fix in $25M round

Amgen bets on stem cell company Fortuna Fix in $25M round

Endpoints

Flag link:

A Change in Direction on Stem Cell Policy? It’s About Time

A Change in Direction on Stem Cell Policy? It’s About Time

FDA Law Blog

Flag link:

CSL snags a preclinical stem cell therapy in $416M Calimmune buyout

CSL snags a preclinical stem cell therapy in $416M Calimmune buyout

Endpoints

Flag link:

J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it

J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it

Endpoints

Flag link:

New Texas Law on Stem Cell Treatments: Showdown With FDA Coming?

New Texas Law on Stem Cell Treatments: Showdown With FDA Coming?

RAPS.org

Flag link:

Athersys And Aurinia Target Human And Animal Health

Athersys And Aurinia Target Human And Animal Health

Seeking Alpha

Aurinia Pharmaceuticals

Flag link:

Texas on track to become first state to explicitly back stem cell therapies

Texas on track to become first state to explicitly back stem cell therapies

Stat

Flag link:

Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it

Five months, $98.5M and a PhII drug from Novartis later, Magenta Therapeutics is flooring it

Endpoints

Magenta Therapeutics

Flag link:

How AbbVie Is Attacking Tumors at Their Roots

How AbbVie Is Attacking Tumors at Their Roots

Motley Fool

Flag link:

Three patients blinded by stem cell procedure, physicians say

Three patients blinded by stem cell procedure, physicians say

Stat

clinical trials

macular degeneration

Flag link:

9 cardiology breakthroughs you need to know

9 cardiology breakthroughs you need to know

Mass Device

robotic heart sleeve

aortic stenosis

Flag link:

Pages